Another gene editing death in China, this time a boy with DMD

Another gene editing death in China, this time a boy with DMDTwo weeks after reports emerged of a gene editing death in China of a 6-year-old girl treated for Snijders Blok-Campeau syndrome, Chinese company Huidagene Therapeutics Co. Ltd. disclosed the death of a young boy receiving its gene editing therapy, HG-302, for Duchenne muscular dystrophy (DMD).